Skip to main navigation
Leap therapeutics
Leap therapeutics
  • About
    • About
    • Contact Us
  • Pipeline
    • Pipeline
    • DKN-01 programs
      • Gastric Cancer
      • Colorectal Cancer
      • Endometrial Cancer
      • Prostate Cancer
      • Lung Cancer
    • Anti-CLDN18.2 programs
      • FL-301 (NBL-015)
      • FL-302 (NBL-016)
    • FL-501
  • Science
    • Science
    • DKK1
    • DKN-01
    • Claudin18.2
    • GDF15
  • Patients
    • Patients
    • Expanded Access
  • Careers
  • Investors
    • Investors
    • Stock Information
    • News Releases
    • Presentations & Events
    • Financial Information
    • Corporate Governance
    • Information Request

Tax
Information

image description
  • Stock Quote & Chart
  • Historical Price Lookup
  • Tax Information

Tax Information

Jan 23, 2017
IRS Form 8937 183.5 KB
  • image Print Page Print Page
  • image Email Alerts Email Alerts
  • image Contact Us Contact Us
image description
image description
Leap therapeutics
47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 USA
+1 617 714 0360

Business inquiries
bd@leaptx.com

Investor inquiries
ir@leaptx.com

  • ABOUT
  • CONTACT US
  • CAREERS
  • PIPELINE
  • DKN-01 PROGRAMS
  • ANTI-CLDN18.2 PROGRAMS
  • FL-501
  • PATIENTS
  • EXPANDED ACCESS
  • SCIENCE
  • DKK1
  • DKN-01
  • CLAUDIN18.2
  • GDF15
  • INVESTORS
  • STOCK INFORMATION
  • NEWS RELEASES
  • PRESENTATIONS & EVENTS
  • FINANCIAL INFORMATION
  • CORPORATE GOVERNANCE
  • INFORMATION REQUEST
  • © 2023 Leap Therapeutics, Inc.
  • All Rights Reserved.
  • Terms of Use
  • Privacy Policy
  • Cookie Policy